Cognitive stimulation as an intervention to strengthen cognition and quality of life as well as to prevent a delirium in inpatients with mild cognitive impairment and dementia: a pilot study to examine the feasibility of the intervention and of the study design for preparing a randomized controlled trial

Cognitive stimulation as an intervention to strengthen cognition and quality of life as well as to prevent a delirium in inpatients with mild cognitive impairment and dementia: a pilot study to examine the feasibility of the intervention and of the study design for preparing a randomized controlled trial - CogStim-G

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00016639

Enrollment

Registered

2019-04-08

Start date

2019-04-08

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F00-F09

Interventions

Group 1: Cognitive stimulation "NEUROvitalis Senseful" as a group intervention (per patient: 8 sessions over a period of 2 weeks)

Eligibility

Sex/Gender

All

Age

60 Years to No maximum

Inclusion criteria

Inclusion criteria: Inpatient stay in the geriatric clinic of the Johanniter Hospital Bonn; mild cognitive impairment or mild to moderate dementia (operationalized by a total MMST score between 10 and 25 points and a total DemTec score of = 12 points; age: = 60 years; the participant is able to sit at the table to take part in the neuropsychological and clinical tests and in the cognitive stimulation program; mother tongue German or very good knowledge of German; good or sufficiently corrected visual and auditory ability

Exclusion criteria

Exclusion criteria: Acute suicidal tendencies; serious neurological and/or psychiatric disorders with cognitive symptoms (persistent or past; psychoses, epilepsy, stroke, traumatic brain injury, brain tumours); other serious or life-threatening comorbidities that are an obstacle to participate in the study; bedridden patients

Design outcomes

Primary

Measure	Time frame
Satisfaction of participants, operationalised via a questionnaire for measuring patient satisfaction (ZUF-8; self assessment; measurement takes place post-intervention)	—

Secondary

Measure	Time frame
Expectations of the cognitive stimulation program (operationalized via the Credibility/Expectancy Questionnaire (CEQ; self-assessment; pre- and post-intervention)); training diary (questionnaire on motivation, mood, satisfaction and stress; self-assessment; collected immediately before and after the individual cognitive stimulation sessions); experiences of the occupational therapists conducting the intervention in carrying out the program (semistructured interviews; post-intervention); global cognition (Mini-Mental Status Examination, MMSE; DemTect; neuropsychological tests; pre- and post-intervention); activities of daily living (Multiple Object Test, MOT; neuropsychological test; Barthel index; external assessment; pre- and post-intervention); quality of life (Quality of Life in Alzheimer's Disease, QoL-AD; self-assessment; pre- and post-intervention); depression (Geriatric Depression Scale, GDS; self-assessment; pre- and post-intervention); anxiety (Hospital Anxiety and Depression Scale, HADS; subscale anxiety; self-assessment; pre- and post-intervention); apathy (Apathy Evaluation Scale, AES-10; self-assessment; pre- and post-intervention); risk of delirium (Confusion Asssessment Method, CAM; external assessment; pre- and post-intervention); clinical overall impression (Clinical Clobal Impression Scale, CGI; external assessment; pre- and post-intervention)	—

Measure

Time frame

Expectations of the cognitive stimulation program (operationalized via the Credibility/Expectancy Questionnaire (CEQ; self-assessment; pre- and post-intervention)); training diary (questionnaire on motivation, mood, satisfaction and stress; self-assessment; collected immediately before and after the individual cognitive stimulation sessions); experiences of the occupational therapists conducting the intervention in carrying out the program (semistructured interviews; post-intervention); global cognition (Mini-Mental Status Examination, MMSE; DemTect; neuropsychological tests; pre- and post-intervention); activities of daily living (Multiple Object Test, MOT; neuropsychological test; Barthel index; external assessment; pre- and post-intervention); quality of life (Quality of Life in Alzheimer's Disease, QoL-AD; self-assessment; pre- and post-intervention); depression (Geriatric Depression Scale, GDS; self-assessment; pre- and post-intervention); anxiety (Hospital Anxiety and Depression Scale, HADS; subscale anxiety; self-assessment; pre- and post-intervention); apathy (Apathy Evaluation Scale, AES-10; self-assessment; pre- and post-intervention); risk of delirium (Confusion Asssessment Method, CAM; external assessment; pre- and post-intervention); clinical overall impression (Clinical Clobal Impression Scale, CGI; external assessment; pre- and post-intervention)

—

Countries

Germany

Contacts

Public ContactLena Haarmann

Uniklinik Köln, Medizinische Psychologie | Neuropsychologie und Gender Studies

lena.haarmann@uk-koeln.de+49 221 478-85474

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026